Abbott's FreeStyle Libre 2 and 3 are the first and only patient-applied continuous glucose monitoring (CGM) systems to be ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Apple might disrupt the world of consumer tech once again. The US-based tech giant has reportedly developed a secret app that monitors blood sugar. The company is testing two tools to try and ...

Abbott today announced that its FreeStyle Libre 2 and 3 systems can now be worn during common imaging procedures, such as X-rays, CT scans and MRIs*. The U.S. Food and Drug Administration (FDA) ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Tidepool today announced a new data integration with Abbott for the company's FreeStyle Libre continuous glucose monitors ...

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a new data integration partnership with continuous glucose monitoring (CGM) manufacturer Abbott .

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a new data integration with continuous glucose monitoring (CGM) manufacturer Abbott (NYSE ... able ...

Tidepool, a software company committed to innovations in diabetes management, is thrilled to announce a new data integration with continuous glucose monitoring (CGM) manufacturer Abbott (NYSE ... able ...

DexCom's stock fell sharply after mixed Q2 earnings and lowering full-year guidance, signaling a revaluation phase with lower ...

The shift towards glucose-sensing technology has heralded a new era in diabetes management, moving from occasional, reactive ...